Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
GSK's Calpol a well-known trademark: High CourtThe Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This desig...
19 May, 2026, 02.02 AM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
18 May, 2026, 10.31 PM IST
Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
03 May, 2026, 12.42 AM IST
I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's...
19 Feb, 2025, 09.51 AM IST
CCI approves Corona Remedies-GlaxoSmithKline dealDilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill.
07 Mar, 2017, 11.13 PM IST
GlaxoSmithKline Pharma Q2 net dips 25 per cent at Rs 96 croreThe company had posted a net profit of Rs 128.67 crore for the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a filing to ...
31 Oct, 2015, 04.06 PM IST
GSK Pharma completes deal with Novartis HealthcareDrug firm GlaxoSmithKline Pharmaceuticals has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis...
30 Sep, 2015, 07.16 PM IST
GSK Pharma to transfer cancer drug portfolio to Novartis armGlaxoSmithKline Pharmaceuticals board approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquirin...
12 Feb, 2015, 09.10 PM IST
GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...
10 Mar, 2014, 04.04 PM IST
FIPB clears GlaxoSmithKline's Rs 6,400 cr FDI proposalFIPB today cleared Rs 6,400 crore FDI proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm.
13 Jan, 2014, 02.57 PM IST
GSK's open offer for buying stake in Indian arm from February 7-21GlaxoSmithKline Plc's Rs 6,389.02 crore open offer to pick up 24.33 per cent stake in its Indian arm GlaxoSmithKline Pharma will start from...
24 Dec, 2013, 04.32 PM IST
GlaxoSmithKline Pharma Q1 net up 37.52 per cent at Rs 169 croreGlaxoSmithKline Pharmaceuticals today reported a 37.52 per cent rise in its net profit to Rs 169.01 crore for the first quarter ended March...
07 May, 2013, 02.30 PM IST
- Morgan Stanley cuts GlaxoSmithKline Pharma to 'under-weight'
Morgan Stanley cut its rating on GSK Pharma to "under-weight", citing expectations the drug maker will post modest growth.
28 Feb, 2013, 09.20 AM IST
- GlaxoSmithKline net up 18 pc at Rs 136.74 crore
GlaxoSmithKline Pharmaceuticals said its net profit rose by 18.18 per cent to Rs 136.74 crore for the quarter ended December 31, 2011.
16 Feb, 2012, 03.30 PM IST
- GlaxoSmithKline Pharma to launch more vaccines in India
Drug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
21 Apr, 2008, 09.36 PM IST
- FDA raids fake thyroid drug makers in Mumbai
The State Food and Drug Administration (FDA) intelligence wing has conducted raids on manufacturers of spurious thyroid drugs and is lookin...
20 Mar, 2007, 12.17 AM IST